Assessment of progression and treatment response of optic pathway glioma with positron emission tomography using α-[11C] Methyl-L-Tryptophan

Molecular Imaging and Biology

Volumn 9, Issue 3, 2007, Pages 106-109

  Peng, Fangyu ^a   Juhasz, Csaba ^a   Bhambhani, Kanta ^a   Wu, Dafang ^a   Chugani, Diane C ^a   Chugani, Harry T ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Optical pathway glioma; Positronemission tomography

Indexed keywords

CARBOPLATIN; N METHYLTRYPTOPHAN C 11; NARCOTIC ANALGESIC AGENT; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; VINCRISTINE;

ADOLESCENT; ARTICLE; ASTROCYTOMA; BRAIN SCINTISCANNING; CANCER GROWTH; CASE REPORT; CLINICAL FEATURE; CORRELATION ANALYSIS; DRUG UPTAKE; FEMALE; HEADACHE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMAGE QUALITY; IMAGE RECONSTRUCTION; MULTIPLE CYCLE TREATMENT; NEUROOPHTHALMOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NERVE GLIOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOACTIVITY; RETREATMENT; TREATMENT DURATION; TREATMENT RESPONSE; TUMOR BIOPSY; VISUAL ACUITY;

ADOLESCENT; CARBON RADIOISOTOPES; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; OPTIC NERVE GLIOMA; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TRYPTOPHAN;

EID: 34248155811     PISSN: 15361632     EISSN: 18602002     Source Type: Journal    
DOI: 10.1007/s11307-007-0090-7     Document Type: Article

References (14)

1. Thiagalingam S, Flaherty M, Billson F, et al. (2004) Neurofibromatosis type 1 and optic pathway gliomas. Ophthalmology 111:568-577
2. Singhal S, Birch JM, Kerr B, et al. (2002) Neurofibromatosis type 1 and sporadic optic gliomas. Arch Dis Child 87:65-70
3. Hoffman HJ, Humphreys RP, Drake JM, et al. (1992) Optic pathway/ hypothalamic gliomas: A dilemma in management. Pediatr Neurosurg 19:186-189
4. Listernick R, Louis DN, Packer RJ, Gutamann DH (1997) Optic pathway gliomas in children with neurofibromatosis 1: Consensus statement from the NF1 optic pathway glioma task force. Ann Neurol 41:143-149
5. Chateil JF, Soussotte C, Pedespan JM, et al. (2001) MRI and clinical differences between optic pathway tumors in children with and without neurofibromatosis. Br J Radiol 74:24-31
6. Benard F, Romsa J, Hustinx R (2003) Imaging gliomas with positron emission tomography and single-photon emission computed tomography. Semin Nucl Med 33:148-162
7. 11C]methyl-L-tryptophan in human brain tumors. J Cereb Blood Flow Metab 26:345-57
8. Bergstroem M, Litton J, Bohm C, Blomquist G (1982) Determination of object contour from projections for attenuation correction in cranial positron emission tomography. J Comput Assist Tomogr 6:365-72
9. Pietrzyk U, Herholz K, Fink G, et al. (1994) An interactive technique for three-dimensional image registration: Validation for PET, SPECT, MRI, and CT brain studies. J Nucl Med 35:2011-2018
10. C-11] alpha-methyl-tryptophan kinetics for the estimation of serotonin synthesis rate in vivo. J Cereb Blood Flow Metab 17:659-669
11. Chugani DC, Muzik O, Behen M, et al. (1999) Developmental changes in brain serotonin synthesis capacity in autistic and nonautistic children. Ann Neurol 45:287-295
12. Packer RJ, Lange B, Ater J, et al. (1993) Carboplatin and vincristine for recurrent and newly diagnosed low-grade gliomas of childhood. J Clin Oncol 11:850-856
13. Diksic M, Nagahiro S, Sourkes TL, Yamamoto YL (1990) A new method to measure brain serotonin synthesis in vivo. I. Theory and basic data for a biological model. J Cereb Blood Flow Metab 9:1-12
14. Chugani DC, Muzik O (2000) Alpha [C-11] methyl-L-tryptophan PET maps brain serotonin synthesis and kynurenine pathway metabolism. J Cereb Blood Flow Metab 20:2-9